Screener
Apogee Therapeutics, Inc. APGE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDED MARCH 31, 2026 | THREE MONTHS ENDED MARCH 31, 2025 |
|---|---|---|
| Purchases of marketable securities | (183,244) | (98,201) |
| Maturities of marketable securities | 147,895 | 115,500 |
| Purchases of property and equipment | — | (4,317) |
| Net cash (used in) provided by investing activities | (35,349) | 12,982 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock, net of issuance costs | 378,169 | — |
| Proceeds from issuance of common stock under the ATM Facility, net of issuance costs | 28,934 | — |
| Proceeds from exercise of options | 4,064 | 622 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s investing cash flow?
- Apogee Therapeutics, Inc. (APGE) reported investing cash flow of -$35.35M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Apogee Therapeutics, Inc.'s investing cash flow decreased by 372.3% year-over-year, from $12.98M to -$35.35M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Apogee Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude